Literature DB >> 929122

Naproxen concentrations in serum, synovial fluid, and synovium.

S Jalava, H Saarimaa, M Anttila, H Sundquist.   

Abstract

Naproxen levels in serum, synovial fluid and synovium of eighteen patients with "classical" or "definite" rheumatoid arthritis and chronic knee effusion were studied. After oral administration of 250 mg naproxen twice daily, naproxen levels in synovial fluid were found to be more than half as high as in serum. Even in synovium itself naproxen levels were appreciable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929122     DOI: 10.3109/03009747709095441

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  19 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

3.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  Concentration of azapropazone in synovial tissues and fluid.

Authors:  H Spahn; K Thabe; E Mutschler; K Tillmann; I Gikalov
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  Correlation plasma levels, NSAID and therapeutic response.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

6.  Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid.

Authors:  A Gaucher; P Netter; G Faure; J P Schoeller; A Gerardin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

8.  Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.

Authors:  S Wanwimolruk; P M Brooks; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

9.  Effect of tenidap on cartilage integrity in vitro.

Authors:  J T Dingle; M R Leeming; J J Martindale
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

10.  D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.

Authors:  D A Joyce; R O Day
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.